Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6192893 | Journal of Thoracic Oncology | 2015 | 7 Pages |
Abstract
It would be acceptable to perform selective LND in patients with c-stage I NSCLC with ground glass opacity- predominant tumor. Elevated serum carcinoembryonic antigen was associated with upper mediastinal lymph node involvement in lower-lobe primary lung adenocarcinoma with radiologically solid-predominant tumor. We should be careful when applying selective LND to patients with solid-predominant tumor, especially located in the lower lobe.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tomohiro MD, Keiju MD, Tomohiro MD, Tomoyuki MD, Genichiro MD, Junji MD, Masahiro MD, Hiroshige MD, Kanji MD,